-
Signature
-
/s/ Joan Aristei as Attorney-in-Fact for Jason Wilk
-
Issuer symbol
-
DAVE
-
Transactions as of
-
19 Sep 2025
-
Net transactions value
-
-$18,812,564
-
Form type
-
4
-
Filing time
-
22 Sep 2025, 16:26:26 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Wilk Jason |
Chief Executive Officer, Director |
C/O DAVE INC., 1265 SOUTH COCHRAN AVENUE, LOS ANGELES |
/s/ Joan Aristei as Attorney-in-Fact for Jason Wilk |
22 Sep 2025 |
0001867755 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
DAVE |
Class A Common Stock |
Options Exercise |
$0 |
+81,693 |
+37% |
$0.000000 |
299,547 |
19 Sep 2025 |
Direct |
F1 |
| transaction |
DAVE |
Class A Common Stock |
Sale |
$17,300,512 |
-75,151 |
-25% |
$230.21 |
224,396 |
19 Sep 2025 |
Direct |
F2, F3 |
| transaction |
DAVE |
Class A Common Stock |
Sale |
$1,512,052 |
-6,542 |
-2.9% |
$231.13 |
217,854 |
19 Sep 2025 |
Direct |
F2, F4 |
| holding |
DAVE |
Class A Common Stock |
|
|
|
|
|
47,882 |
19 Sep 2025 |
By Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
DAVE |
Class V Common Stock |
Options Exercise |
$0 |
-81,693 |
-5.9% |
$0.000000 |
1,314,082 |
19 Sep 2025 |
Class A Common Stock |
81,693 |
|
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: